Growth Metrics

Tandem Diabetes Care (TNDM) Convertible Debt (2020 - 2025)

Historic Convertible Debt for Tandem Diabetes Care (TNDM) over the last 6 years, with Q3 2025 value amounting to $309.6 million.

  • Tandem Diabetes Care's Convertible Debt rose 57.21% to $309.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.6 million, marking a year-over-year increase of 57.21%. This contributed to the annual value of $308.3 million for FY2024, which is 815.02% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Convertible Debt of $309.6 million as of Q3 2025, which was up 57.21% from $309.1 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Convertible Debt ranged from a high of $347.5 million in Q1 2024 and a low of $280.2 million during Q1 2021
  • In the last 5 years, Tandem Diabetes Care's Convertible Debt had a median value of $284.1 million in 2023 and averaged $294.2 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first soared by 4364.35% in 2021, then plummeted by 1116.33% in 2025.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Convertible Debt stood at $281.5 million in 2021, then increased by 0.63% to $283.2 million in 2022, then increased by 0.64% to $285.0 million in 2023, then rose by 8.15% to $308.3 million in 2024, then grew by 0.43% to $309.6 million in 2025.
  • Its Convertible Debt was $309.6 million in Q3 2025, compared to $309.1 million in Q2 2025 and $308.7 million in Q1 2025.